Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Harminder Sikand, PharmD"'
Autor:
Kevin Kavanagh, PharmD, BCPP, Kimberly Tallian, PharmD, APh, BCPP, Joe A. Sepulveda, MD, FAPA, FASAM, Sarah Rojas, MD, Shedrick Martin, PharmD, BCPP, Harminder Sikand, PharmD
Publikováno v:
Mental Health Clinician, Vol 12, Iss 4, Pp 241-246 (2023)
Introduction: Buprenorphine (BUP), generally prescribed as buprenorphine/naloxone, is a key component of medication-assisted treatment (MAT) to manage opioid use disorder. Studies suggest higher doses of BUP increase treatment adherence. Routine urin
Externí odkaz:
https://doaj.org/article/3f266949f50e4b609e123df4d2e85861
Autor:
Davidson JE; Judy E. Davidson, DNP, RN, FCCM Director, Research Integration and Management, Scripps Clinical Research Center, La Jolla, California. Donna Agan, EdD Director of Operations Integration, Scripps Mercy Hospital, San Diego, California. Dan L. Ballard Jr, BS Process Validation Engineer, Welch Allyn Monitoring, Beaverton, Oregon. Huu Tam D. Truong, MD Cardiology Fellow, Cardiology Department, University of Arizona, Sarver Heart Center, Tucson. Christine M. Bridgen, PharmD Clinical Pharmacist, Department of Pharmacy, Scripps Encinitas Hospital, San Diego, California. Steven Rubino Network + Clinical Systems Specialist, Lead, Biomedical Engineering Department, Scripps Mercy Hospital, San Diego, California. Harminder Sikand, PharmD Clinical Director, Department of Pharmacy, Scripps Mercy Hospital, San Diego, California. Joseph Stein, MD, FACC Electrophysiologist, Division of Cardiology/Electrophysiology, Scripps Mercy Hospital, San Diego, California., Agan D, Ballard DL Jr, Truong HT, Bridgen CM, Rubino S, Sikand H, Stein J
Publikováno v:
The Journal of cardiovascular nursing [J Cardiovasc Nurs] 2013 Nov-Dec; Vol. 28 (6), pp. 584-90.